🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vikas V. Dukhande

St. John's University

ORCID: 0000-0002-9288-715X
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma”.

Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma

Pharmaceutics(2021)10.3390/pharmaceutics13071005
N/A
0DataRank · unranked
63 citations

Aishwarya Saraswat, Zeng-Hui Wei, Manas Yogendra Agrawal, Vikas V. Dukhande, Sandra E. Reznik +2 more

Repurposing an Antiepileptic Drug for the Treatment of Glioblastoma

Pharmaceutical Research(2022)10.1007/s11095-022-03399-4
N/A
0DataRank · unranked
16 citations

Ali Alnakhli, Hari Priya Vemana, Shraddha Bhutkar, Aaron Muth, Vikas V. Dukhande +1 more

Metabolic alterations and mitochondrial dysfunction underlie hepatocellular carcinoma cell death induced by a glycogen metabolic inhibitor

Biochemical Pharmacology(2022)10.1016/j.bcp.2022.115201
N/A
0DataRank · unranked
13 citations

Olivia J. Stephenson, Hari Priya Vemana, Anjali Yadav, Shraddha Bhutkar, Louis D. Trombetta +2 more

Evaluation of a Combination of an HDAC Inhibitor and a Cell Cycle Inhibitor in Pancreatic Cancer Cells

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r6295
N/A
0DataRank · unranked
0 citations

Anjali Yadav, Vikas V. Dukhande, Shraddha Bhutkar

Mass Spectrometry‐based Proteomics in Deciphering Hormonal Regulation of Ubiquitin Linkages

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r5856
N/A
0DataRank · unranked
0 citations

Ehab M. Abo‐Ali, Rinat R. Abzalimov, Vikas V. Dukhande, Hari Priya Vemana

Mechanistic Elucidation of an Anti‐Epileptic for the Treatment of Glioblastoma

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r6209
N/A
0DataRank · unranked
0 citations

Ali Alnakhli, Hari Priya Vemana, Shraddha Bhutkar, Shrikant Barot, Aaron Muth +2 more

The effect of hormones insulin and glucagon on ubiquitin modifications elucidated by proteomics in liver cells

Life Sciences(2023)10.1016/j.lfs.2023.121935
N/A
0DataRank · unranked
6 citations

Vikas V. Dukhande, Hari Priya Vemana

Novel gene therapy for drug-resistant melanoma: Synergistic combination of PTEN plasmid and BRD4 PROTAC-loaded lipid nanocarriers

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102292
N/A
0DataRank · unranked
23 citations

Hari Priya Vemana, Vikas V. Dukhande, Ketan Patel, Aishwarya Saraswat

Palmitate-induced downregulation of lipocalin prostaglandin D2 synthase accompanies hepatic lipid accumulation in HepG2 cells

Molecular and Cellular Endocrinology(2025)10.1016/j.mce.2025.112615
N/A
0DataRank · unranked
2 citations

Md Asrarul Islam, Deekshith Shetty, Vikas V. Dukhande, Sunil Kumar, Rhema Khairnar

Ubiquitination of glucose and lipid metabolic proteins is altered in diabetic rat livers

Life Sciences(2025)10.1016/j.lfs.2025.124120
N/A
0DataRank · unranked
0 citations

Deekshith Shetty, Rhema Khairnar, Sunil Kumar, Vikas V. Dukhande, Ehab M. Abo‐Ali

Revealing the biochemical regulations of L-PGDS in hepatic insulin-resistance using HepG2 cells

Prostaglandins & Other Lipid Mediators(2025)10.1016/j.prostaglandins.2025.107052
N/A
0DataRank · unranked
0 citations

Md Asrarul Islam, Kuljeet Singh, Deekshith Shetty, Anjali Yadav, Vikas V. Dukhande +2 more